Antifungal susceptibility profile

Profile of Candidiasis from a tertiary care hospital of North India: A 5 year study (DOI: https://doi.org/10.1016/j.jpsic.2015.10.018)

ResistantIntermediateSusceptible0102030405060708090100PercentageDrug: Fluconazole ResistantIntermediateSusceptible0102030405060708090100PercentageDrug: Ketoconazole ResistantIntermediateSusceptible0102030405060708090100PercentageDrug: Amphotericin B ResistantIntermediateSusceptible0102030405060708090100PercentageDrug: Clotrimazole